Primel has announced the ground-breaking results from a controlled evaluation of its hand sanitiser product in a care home in Manchester.
The aim of the study was to compare the efficacy of Primel Skin Protection powered by TridAnt against a well-known, regularly-used product on the hands of 35 healthcare workers over a 10-day period.
The evaluation was carried out by Perfectus Biomed Group, part of NAMSA and a leader in microbiology testing services for a variety of sectors including wound care, medical devices, and infectious diseases.
And the results demonstrated that Primel Skin Protection provides superior protection against pathogens, including some of the most-drug resistant-microbes, on immediate application and over a prolonged period of time, as well as showing surfaces were cleaner after contact.
Real-world results
The care home evaluation represents the first comprehensive comparison of a long-term hand sanitiser efficacy in a real-world scenario.
The study recovered samples taken from the hands of healthcare workers at various different points:
- Before the application of either product (regularly-used hand sanitiser and Primel Skin Protection)
- Immediately after application of either product
- One hour after application of either product
During the one-hour period, the volunteers wore gloves, which were collected and samples taken from the inside at the end of the time period, to assess the transmission of germs from hands to gloves.
Understanding the effectiveness of our Skin Protection in a real-world setting is crucial to improving hand hygiene strategies in healthcare settings and it supports the fact users are able to wash their hands once per patient, which helps to improve the quality of care and productivity while saving time, water, and consumables
Overall, the analysis showed that application of Primel Skin Protection resulted in the recovery of significantly-less-viable micro-organisms compared to the established regularly-used hand sanitiser across all time points.
The evaluation found that Primel Skin Protection was 21% more effective after immediate application compared to the well-known, regularly-used hand sanitiser.
And the second result confirmed that Primel Skin Protection was 46% more effective after one hour of use compared to the traditional solution.
Additionally, the inside of the volunteers’ gloves were tested after the one-hour timepoint, and the gloves of Primel Skin Protection users were found to have 84% less pathogens.
The findings showed Primel Skin Protection was 21% more effective after immediate application than the well-known, commonly-used hand sanitiser
Superior performance
After immediate application Primel Skin Protection was 75% effective and after one hour 72% effective, therefore maintaining its efficacy, while the regularly-used hand sanitiser dropped its efficacy considerably from 54%-26%, respectively.
Not only was Primel Skin Protection able to maintain its efficacy, it was more effective at one hour compared to the immediate effect of the regularly-used hand sanitiser.
Further testing has proven that Primel Skin Protection can disinfect pathogens, including some of the most-drug-resistant microbes, in 15 seconds, significantly quicker than other options regularly used.
Arjun Luthra, chief executive of Primel, said: “The care home evaluation has demonstrated Primel Skin Protection’s superiority in hand protection when compared against existing standard of care which uses well-known and regularly-used hand sanitiser products.
Overall, Primel Skin Protection showed an increase in antimicrobial activity across all time points when compared to a well-known and regularly-used hand sanitiser
“Understanding the effectiveness of our Skin Protection in a real-world setting is crucial to improving hand hygiene strategies in healthcare settings and it supports the fact users are able to wash their hands once per patient, which helps to improve the quality of care and productivity while saving time, water, and consumables.”
Primel Skin Protection has a long-term (48 hours) and broad spectrum of efficacy which includes Gram negative and Gram positive bacteria, enveloped and non-enveloped viruses as well as yeast.
“The further significant result of this evaluation was Primel Skin Protection’s ability to demonstrate its ‘kill on touch’ technology in a real-world scenario,” said Luthra.
Targeting germs
“This is the first time that a product was able to demonstrate the ability to disinfect the surface with a user’s touch.
“This proves that Primel Skin Protection’s technology was able to reduce the number of pathogens that are transferred from the hands of healthcare workers to surfaces they interact with.
“Overall, Primel Skin Protection showed an increase in antimicrobial activity across all time points when compared to a well-known and regularly-used hand sanitiser.
“This suggests it has a greater sustained antimicrobial efficacy than any other hand sanitiser on the market today.”
The test report from Perfectus Biomed Group concluded: “Over 10 days of sampling, Primel Skin Protection achieved a significantly-greater reduction in total viable recovery than the reference hand sanitiser one hour after application, both from the hands of the healthcare workers and the gloves that they were wearing.
“Primel Skin Protection application resulted in a lower recovery of total viable organisms compared to the reference hand sanitiser immediately after application.”